Acceptability of Antiretroviral Pre-Exposure Prophylaxis from a Cohort of Sexually Experienced Young Transgender Women in Two U.S. Cities

Emtricitabine/tenofovir disoproxil fumarate as Pre-exposure Prophylaxis (PrEP) is can prevent HIV infection among at-risk individuals, including young transgender women (YTW). We used baseline data from 230 HIV-uninfected YTW (ages 16–29 years) who were enrolled in Project LifeSkills during 2012–201...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:AIDS Behav
Hlavní autoři: Restar, Arjee J., Kuhns, Lisa, Reisner, Sari L., Ogunbajo, Adedotun, Garofalo, Robert, Mimiaga, Matthew J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6204093/
https://ncbi.nlm.nih.gov/pubmed/29713838
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-018-2127-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky